Lotte Biologics vs Pharmaron Biologics: CDMO Comparison
How does Lotte Biologics compare to Pharmaron Biologics for AAV manufacturing?
Side-by-side comparison of Lotte Biologics and Pharmaron Biologics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
On a 13-modality CDMO landscape, both Lotte Biologics and Pharmaron Biologics qualify as AAV manufacturers; Pharmaron Biologics carries the higher composite Signal Score for AAV programs in this comparison.
What to evaluate for AAV programs
Both Lotte Biologics and Pharmaron Biologics qualify as AAV CDMOs. When choosing between them for AAV programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
Platform & scale
Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record.
Capsid quality
Full/empty capsid ratio and aggregate control drive potency and safety. Ask about AUC, anion-exchange separation, and the analytics package for capsid characterization.
Regulatory readiness
For programs heading to BLA, a strong FDA inspection history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.
Capacity & timelines
AAV manufacturing slots can be constrained. Weigh the capacity signal and clinical-program load before committing.
Frequently asked: Lotte Biologics vs Pharmaron Biologics
How does Lotte Biologics compare to Pharmaron Biologics for AAV manufacturing?
On CDMO Signal's composite Signal Score, Lotte Biologics is 84/100 and Pharmaron Biologics is 87/100; Lotte Biologics has 1 FDA inspection on record vs 3 for Pharmaron Biologics. Both are tracked in the CDMO Signal directory as AAV CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Lotte Biologics or Pharmaron Biologics?
Both Lotte Biologics and Pharmaron Biologics maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Lotte Biologics has 1 FDA inspection on record; Pharmaron Biologics has 3.
Which is better for AAV manufacturing — Lotte Biologics or Pharmaron Biologics?
Both Lotte Biologics and Pharmaron Biologics are tagged as AAV CDMOs in our directory, so both are credible options for AAV programs. The most important differentiator for AAV selection is typically platform & scale: Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Lotte Biologics carries a Signal Score of 84/100 and Pharmaron Biologics carries 87/100 — essentially tied for Pharmaron Biologics. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →